| Quarter | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| 203 | 196 | 245 | 218 | 280 | |
Growth YoY Revenue Growth YoY% | 7.4 | 43.2 | |||
| 145 | 145 | 183 | 173 | 188 | |
| 58 | 50 | 62 | 45 | 92 | |
OPM OPM% | 28.5 | 25.7 | 25.3 | 20.7 | 32.7 |
| 3 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 5 | 6 | 7 | 6 | 6 |
Depreciation DepreciationCr | 11 | 11 | 20 | 22 | 22 |
PBT PBTCr | 45 | 33 | 35 | 18 | 64 |
| 15 | 14 | 8 | 3 | 12 | |
| 30 | 19 | 28 | 14 | 52 | |
Growth YoY PAT Growth YoY% | -53.0 | 169.1 | |||
NPM NPM% | 14.7 | 9.8 | 11.2 | 6.5 | 18.5 |
| 5.4 | 3.5 | 4.8 | 2.2 | 8.2 |
| Quarter | Jun 2025 | Sep 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| 203 | 196 | 245 | 218 | 280 | |
Growth YoY Revenue Growth YoY% | 7.4 | 43.2 | |||
| 145 | 145 | 183 | 173 | 188 | |
| 58 | 50 | 62 | 45 | 92 | |
OPM OPM% | 28.5 | 25.7 | 25.3 | 20.7 | 32.7 |
| 3 | 0 | 0 | 0 | 0 | |
Interest Expense Interest ExpenseCr | 5 | 6 | 7 | 6 | 6 |
Depreciation DepreciationCr | 11 | 11 | 20 | 22 | 22 |
PBT PBTCr | 45 | 33 | 35 | 18 | 64 |
| 15 | 14 | 8 | 3 | 12 | |
| 30 | 19 | 28 | 14 | 52 | |
Growth YoY PAT Growth YoY% | -53.0 | 169.1 | |||
NPM NPM% | 14.7 | 9.8 | 11.2 | 6.5 | 18.5 |
| 5.4 | 3.5 | 4.8 | 2.2 | 8.2 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 633 | 682 | 567 | 716 | 752 | 869 |
Growth Revenue Growth% | 7.7 | -16.9 | 26.4 | 4.9 | 15.7 | |
| 439 | 552 | 498 | 545 | 550 | 631 | |
| 194 | 130 | 69 | 171 | 202 | 238 | |
OPM OPM% | 30.6 | 19.1 | 12.2 | 23.9 | 26.9 | 27.4 |
| 7 | 3 | 6 | 7 | 4 | -6 | |
Interest Expense Interest ExpenseCr | 6 | 2 | 7 | 7 | 16 | 25 |
Depreciation DepreciationCr | 22 | 26 | 29 | 39 | 43 | 53 |
PBT PBTCr | 173 | 105 | 39 | 132 | 147 | 153 |
| 48 | 28 | 15 | 31 | 50 | 43 | |
PAT PATCr | 124 | 77 | 25 | 101 | 97 | 110 |
Growth PAT Growth% | -37.8 | -68.2 | 312.9 | -4.4 | 13.4 | |
NPM NPM% | 19.6 | 11.3 | 4.3 | 14.2 | 12.9 | 12.6 |
| 113.0 | 71.0 | 21.5 | 91.5 | 88.5 | 19.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
Revenue RevenueCr | 633 | 682 | 567 | 716 | 752 | 869 |
Growth Revenue Growth% | 7.7 | -16.9 | 26.4 | 4.9 | 15.7 | |
| 439 | 552 | 498 | 545 | 550 | 631 | |
| 194 | 130 | 69 | 171 | 202 | 238 | |
OPM OPM% | 30.6 | 19.1 | 12.2 | 23.9 | 26.9 | 27.4 |
| 7 | 3 | 6 | 7 | 4 | -6 | |
Interest Expense Interest ExpenseCr | 6 | 2 | 7 | 7 | 16 | 25 |
Depreciation DepreciationCr | 22 | 26 | 29 | 39 | 43 | 53 |
PBT PBTCr | 173 | 105 | 39 | 132 | 147 | 153 |
| 48 | 28 | 15 | 31 | 50 | 43 | |
PAT PATCr | 124 | 77 | 25 | 101 | 97 | 110 |
Growth PAT Growth% | -37.8 | -68.2 | 312.9 | -4.4 | 13.4 | |
NPM NPM% | 19.6 | 11.3 | 4.3 | 14.2 | 12.9 | 12.6 |
| 113.0 | 71.0 | 21.5 | 91.5 | 88.5 | 19.1 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 11 | 11 | 11 | 11 | 11 | 13 |
Reserves ReservesCr | 510 | 588 | 611 | 704 | 804 | 1,137 |
| 225 | 189 | 228 | 351 | 473 | 528 | |
| 23 | 28 | 140 | 229 | 292 | 104 | |
| 768 | 815 | 990 | 1,295 | 1,580 | 1,781 | |
| 423 | 425 | 400 | 508 | 493 | 486 | |
| 345 | 390 | 590 | 787 | 1,087 | 1,295 | |
| 768 | 815 | 990 | 1,295 | 1,580 | 1,781 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
Equity Capital Equity CapitalCr | 11 | 11 | 11 | 11 | 11 | 13 |
Reserves ReservesCr | 510 | 588 | 611 | 704 | 804 | 1,137 |
| 225 | 189 | 228 | 351 | 473 | 528 | |
| 23 | 28 | 140 | 229 | 292 | 104 | |
| 768 | 815 | 990 | 1,295 | 1,580 | 1,781 | |
| 423 | 425 | 400 | 508 | 493 | 486 | |
| 345 | 390 | 590 | 787 | 1,087 | 1,295 | |
| 768 | 815 | 990 | 1,295 | 1,580 | 1,781 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 174 | 18 | 69 | 188 | 47 | 175 | |
| -96 | -32 | -220 | -206 | -307 | -227 | |
| -79 | 15 | 146 | 22 | 278 | 36 | |
Net Cash Flow Net Cash FlowCr | -1 | 1 | -5 | 3 | 19 | -16 |
Free Cash Flow Free Cash FlowCr | 87 | -55 | -155 | -22 | -261 | -50 |
CFO To PAT CFO To PAT% | 140.4 | 22.9 | 281.9 | 184.9 | 48.8 | 158.9 |
CFO To EBITDA CFO To EBITDA% | 89.9 | 13.6 | 100.5 | 109.5 | 23.4 | 73.4 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 174 | 18 | 69 | 188 | 47 | 175 | |
| -96 | -32 | -220 | -206 | -307 | -227 | |
| -79 | 15 | 146 | 22 | 278 | 36 | |
Net Cash Flow Net Cash FlowCr | -1 | 1 | -5 | 3 | 19 | -16 |
Free Cash Flow Free Cash FlowCr | 87 | -55 | -155 | -22 | -261 | -50 |
CFO To PAT CFO To PAT% | 140.4 | 22.9 | 281.9 | 184.9 | 48.8 | 158.9 |
CFO To EBITDA CFO To EBITDA% | 89.9 | 13.6 | 100.5 | 109.5 | 23.4 | 73.4 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 10,272 | ||||||
Price To Earnings Price To Earnings | 75.8 | ||||||
Price To Sales Price To Sales | 11.8 | ||||||
Price To Book Price To Book | 7.5 | ||||||
EV To EBITDA EV To EBITDA | 44.5 | ||||||
GPM GPM% | 50.8 | 40.3 | 37.3 | 44.9 | 49.5 | 51.6 | 51.6 |
OPM OPM% | 30.6 | 19.1 | 12.2 | 23.9 | 26.9 | 27.4 | 27.4 |
NPM NPM% | 19.6 | 11.3 | 4.3 | 14.2 | 12.9 | 12.6 | 12.6 |
ROCE ROCE% | 31.4 | 16.2 | 5.6 | 14.5 | 12.0 | 11.6 | 11.6 |
ROE ROE% | 23.9 | 12.9 | 4.0 | 14.2 | 11.9 | 9.6 | 9.6 |
ROA ROA% | 16.2 | 9.5 | 2.5 | 7.8 | 6.1 | 6.2 | 6.2 |
| Financial Year | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Current |
|---|---|---|---|---|---|---|---|
Market Cap Market CapitalizationCr | 10,272 | ||||||
Price To Earnings Price To Earnings | 75.8 | ||||||
Price To Sales Price To Sales | 11.8 | ||||||
Price To Book Price To Book | 7.5 | ||||||
EV To EBITDA EV To EBITDA | 44.5 | ||||||
GPM GPM% | 50.8 | 40.3 | 37.3 | 44.9 | 49.5 | 51.6 | 51.6 |
OPM OPM% | 30.6 | 19.1 | 12.2 | 23.9 | 26.9 | 27.4 | 27.4 |
NPM NPM% | 19.6 | 11.3 | 4.3 | 14.2 | 12.9 | 12.6 | 12.6 |
ROCE ROCE% | 31.4 | 16.2 | 5.6 | 14.5 | 12.0 | 11.6 | 11.6 |
ROE ROE% | 23.9 | 12.9 | 4.0 | 14.2 | 11.9 | 9.6 | 9.6 |
ROA ROA% | 16.2 | 9.5 | 2.5 | 7.8 | 6.1 | 6.2 | 6.2 |
| Market CapitalizationMkt CapCr | 17,669 | 16,608 | 11,470 | 10,272 | 8,984 | 5,751 | 5,404 |
| Close PriceClose₹ | 1,436.90 | 849.15 | 548.20 | 1,598.60 | 990.70 | 960.40 | 184.12 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 26.35 | 49.95 | 41.03 | 75.80 | 34.99 | 134.70 | 26.61 |
| Price To SalesPS | 6.58 | 9.02 | 9.80 | 11.82 | 4.16 | 4.71 | 1.96 |
| RevenueRevenueCr | 2,684 | 1,842 | 1,170 | 869 | 2,161 | 1,221 | 2,751 |
| Revenue Growth TTMRev Gr TTM% | 8.2% | 37.3% | 4.0% | 13.4% | 20.1% | 26.8% | |
| PAT Growth TTMPAT Gr TTM% | 26.3% | 142.2% | -13.6% | 7.1% | 16.5% | 75.4% |
| Market CapitalizationMkt CapCr | 17,669 | 16,608 | 11,470 | 10,272 | 8,984 | 5,751 | 5,404 |
| Close PriceClose₹ | 1,436.90 | 849.15 | 548.20 | 1,598.60 | 990.70 | 960.40 | 184.12 |
| IndustryIndustry | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API | Pharma API |
| Price To EarningsPE | 26.35 | 49.95 | 41.03 | 75.80 | 34.99 | 134.70 | 26.61 |
| Price To SalesPS | 6.58 | 9.02 | 9.80 | 11.82 | 4.16 | 4.71 | 1.96 |
| RevenueRevenueCr | 2,684 | 1,842 | 1,170 | 869 | 2,161 | 1,221 | 2,751 |
| Revenue Growth TTMRev Gr TTM% | 8.2% | 37.3% | 4.0% | 13.4% | 20.1% | 26.8% | |
| PAT Growth TTMPAT Gr TTM% | 26.3% | 142.2% | -13.6% | 7.1% | 16.5% | 75.4% |